Processing

Please wait...

PATENTSCOPE will be unavailable a few hours for maintenance reason on Saturday 31.10.2020 at 7:00 AM CET
Settings

Settings

Goto Application

1. WO2007149816 - STRONTIUM COMPOSITIONS AND METHODS OF TREATING OSTEOPOROTIC CONDITIONS

Publication Number WO/2007/149816
Publication Date 27.12.2007
International Application No. PCT/US2007/071466
International Filing Date 18.06.2007
IPC
A61K 33/24 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
33Medicinal preparations containing inorganic active ingredients
24Heavy metals; Compounds thereof
CPC
A61K 31/185
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
A61K 31/19
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
19Carboxylic acids, e.g. valproic acid
A61K 31/4415
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
435having six-membered rings with one nitrogen as the only ring hetero atom
44Non condensed pyridines; Hydrogenated derivatives thereof
4415Pyridoxine, i.e. Vitamin B6
A61K 31/51
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
495having six-membered rings with two ; or more; nitrogen atoms as the only ring heteroatoms, e.g. piperazine ; or tetrazines
505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
506not condensed and containing further heterocyclic rings
51Thiamines, e.g. vitamin B1
A61K 31/525
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
495having six-membered rings with two ; or more; nitrogen atoms as the only ring heteroatoms, e.g. piperazine ; or tetrazines
505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
519ortho- or peri-condensed with heterocyclic rings
525Isoalloxazines, e.g. riboflavins, vitamin B2
A61K 31/714
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
70Carbohydrates; Sugars; Derivatives thereof
7135Compounds containing heavy metals
714Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
Applicants
  • THERAGENEX, LLC [US]/[US] (AllExceptUS)
  • TABBINER, Philip, S. [US]/[US] (UsOnly)
Inventors
  • TABBINER, Philip, S.
Agents
  • BAUM, Allen, R.
Priority Data
11/455,60519.06.2006US
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) STRONTIUM COMPOSITIONS AND METHODS OF TREATING OSTEOPOROTIC CONDITIONS
(FR) COMPOSITIONS DE STRONTIUM ET MÉTHODES DE TRAITEMENT D'AFFECTIONS OSTÉOPOROTIQUES
Abstract
(EN)
A therapeutic dosage form and method for treating an osteoporitic condition is described. The therapeutic dosage form comprises a divalent cationic source of strontium, vitamin B6, vitamin B12 and folic acid or folate. The method comprises administering to a subject in need thereof a therapeutic dosage form comprising a divalent cationic source of strontium, vitamin B6, vitamin B12 and folic acid or folate.
(FR)
L'invention concerne une forme posologique thérapeutique et une méthode de traitement d'une affection ostéoporotique. Cette forme posologique thérapeutique comprend une source cationique divalente de strontium, de la vitamine B6, de la vitamine B12 et de l'acide folique ou du folate. La méthode consiste à administrer, à un sujet nécessitant un tel traitement, une forme posologique thérapeutique comprenant une source cationique divalente de strontium, de la vitamine B6, de la vitamine B12 et de l'acide folique ou du folate.
Latest bibliographic data on file with the International Bureau